Discussions

Ace Therapeutics’ gene therapy development services for glaucoma offer comprehensive solutions that include stem cell-based gene therapy development, siRNA development, gene delivery system engineering, and preclinical testing. Based on years of CRO experience, Ace Therapeutics' integrated development pipeline ensures a seamless end-to-end process, from initial discovery through to preclinical validation, designed to streamline the development timeline and enhance success rates.